| Dr Beth Ann Maier, MD | |
|
266 Fisher Rd, Ste 1, Berlin, VT 05602-9179 | |
| (802) 371-5950 | |
| Not Available |
| Full Name | Dr Beth Ann Maier |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 266 Fisher Rd, Berlin, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982702650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 042-0006268 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Beth Ann Maier, MD 36 Randall St, Ste 1, Waterbury, VT 05676-1571 Ph: (802) 244-7472 | Dr Beth Ann Maier, MD 266 Fisher Rd, Ste 1, Berlin, VT 05602-9179 Ph: (802) 371-5950 |
News Archive
Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease (Creutzfeldt-Jakob disease), and other degenerative diseases are more closely related at the molecular level than many scientists realized, an international team of researchers, including an ESRF researcher, report in the journal Nature.
Is there a relation between the structure of specific regions of the brain and nicotine dependence? This is the question researchers of the Charité - Universitätsmedizin Berlin and of the Physikalisch-Technische Bundesanstalt (PTB), the German National Metrology Institute, have been investigating lately. The results of these investigations extend and specify those of preceding studies: A specific region of the cerebral cortex of smokers is thinner than that of people who have never smoked in their lives.
FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.
Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, today announced that BD Diagnostics, a segment of Becton Dickinson and Company, a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of respiratory syncytial virus (RSV).
› Verified 6 days ago
Colin Matthew Mccreight, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
James R Milne, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 266 Fisher Rd Ste 1, Associates In Pediatrics, Berlin, VT 05602 Phone: 802-371-5950 Fax: 802-371-5951 | |
Deborah Jerard, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 246 Granger Rd, Suite 1, Berlin, VT 05602 Phone: 802-476-9242 Fax: 802-225-5760 | |
Dr. Jessie L Leyse, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-371-4100 | |
Carolyn Sarah Lorenz-greenberg, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 246 Granger Rd, Suite 1, Berlin, VT 05602 Phone: 802-371-5950 Fax: 802-371-5951 | |
Harriott Meyer Shea, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 246 Granger Rd Ste 1, Associates In Pediatrics - Berlin, Berlin, VT 05602 Phone: 802-371-5950 Fax: 802-371-5951 |